IL-6 inhibitors significantly reduced the hazard ratio for relapse as well as the annualized relapse rate of the disease compared to placebo or traditional immunosuppressants. Interleukin (IL)-6 ...

In high-risk pregnancies, patients must commit to antenatal follow-ups as planned so that timely interventions can be introduced, especially in the case of HDFN. A severe case of hemolytic disease of ...

The risk of infection should be carefully weighed before therapies are prescribed in AAV. Therapies used in the management of antineutrophil cytoplasmic (ANCA)-associated vasculitis (AAV) should take ...

The persistence of a high ANCA titer and other symptoms despite a lack of extracapillary proliferations on kidney biopsy led to a diagnosis of AAV. A new case has been reported of a patient with ...

The addition of obinutuzumab to acalabrutinib plus venetoclax improved rates of undetectable minimum residual disease but increased toxicity. SAN DIEGO—A phase 2 trial of acalabrutinib plus venetoclax ...

At the end of treatment, the rate of undetectable MRD in peripheral blood was 81.3% with venetoclax plus obinutuzumab. Two-year rates of progression-free survival were 95.7% with venetoclax plus ...

A case of neuromyelitis optica spectrum disorder triggered by a herpes zoster infection was recently published in the Journal of International Medical Research. “The exact etiology of NMOSD remains ...

It is crucial to diagnose seropositive patients early on and provide prompt treatment to prevent attacks and deficits. Serum antibodies for myelin oligodendrocyte glycoprotein (MOG) were more ...

Which of the statements below about the etiology of immunoglobulin G4-related disease (IgG4-RD) are correct? Select one of the options for each question, then submit your answers to see how well you ...

Intravenous immunoglobulins were started earlier in patients whose disease remained monotruncular compared to those who progressed to multitruncular worsening. Eleven percent of focal or multifocal ...

The first oral liquid form of imatinib offers a more patient-friendly option for certain cancers, including aggressive SM. This new solution addresses longstanding challenges in treatment by providing ...

Of the 3 approaches used to detect KIT mutations, pyrosequencing of genomic DNA was the least sensitive. A new study has investigated the feasibility and sensitivity of mRNA/cDNA analysis instead of ...